CYSTOPURIN Granules for oral solution Ref.[49931] Active ingredients: Potassium citrate

Source: Health Products Regulatory Authority (IE)  Revision Year: 2021  Publisher: Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Ireland

5.1. Pharmacodynamic properties

Pharmacotherapeutic group: potassium
ATC code: A12BA02

Potassium citrate, after absorption, is metabolised and acts to make the urine less acid. A mild diuresis usually follows treatment with potassium citrate.

5.2. Pharmacokinetic properties

Potassium citrate is metabolised, after absorption, to bicarbonate. Bicarbonate ions are excreted in the urine, which is rendered alkaline, and there is an accompanying diuresis.

5.3. Preclinical safety data

None available.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.